SE505146C2 - Partiklar för fördröjd frisättning - Google Patents

Partiklar för fördröjd frisättning

Info

Publication number
SE505146C2
SE505146C2 SE9503672A SE9503672A SE505146C2 SE 505146 C2 SE505146 C2 SE 505146C2 SE 9503672 A SE9503672 A SE 9503672A SE 9503672 A SE9503672 A SE 9503672A SE 505146 C2 SE505146 C2 SE 505146C2
Authority
SE
Sweden
Prior art keywords
active substance
coating
core particles
polymer
particles
Prior art date
Application number
SE9503672A
Other languages
English (en)
Swedish (sv)
Other versions
SE9503672L (sv
SE9503672D0 (sv
Inventor
Nils-Ove Gustafsson
Timo Laakso
Peter Fyhr
Monica Joensson
Original Assignee
Biogram Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogram Ab filed Critical Biogram Ab
Priority to SE9503672A priority Critical patent/SE505146C2/sv
Publication of SE9503672D0 publication Critical patent/SE9503672D0/xx
Priority to CZ19981173A priority patent/CZ293059B6/cs
Priority to EP06010350A priority patent/EP1716849A1/de
Priority to AU73478/96A priority patent/AU699080B2/en
Priority to ES96935641T priority patent/ES2125209T3/es
Priority to EP01117830A priority patent/EP1142569B1/de
Priority to HK98112027.5A priority patent/HK1011182B/en
Priority to JP9515728A priority patent/JP2000501380A/ja
Priority to PCT/SE1996/001091 priority patent/WO1997014408A1/en
Priority to AT01117830T priority patent/ATE326953T1/de
Priority to KR1019980702757A priority patent/KR100482262B1/ko
Priority to IL12405296A priority patent/IL124052A/xx
Priority to PT96935641T priority patent/PT869774E/pt
Priority to DE0869774T priority patent/DE869774T1/de
Priority to US09/051,709 priority patent/US6120787A/en
Priority to DE69636177T priority patent/DE69636177T2/de
Priority to ES01117830T priority patent/ES2267637T3/es
Priority to CA 2234615 priority patent/CA2234615C/en
Priority to AT96935641T priority patent/ATE228826T1/de
Priority to EP96935641A priority patent/EP0869774B1/de
Priority to HU9901205A priority patent/HUP9901205A3/hu
Priority to DK96935641T priority patent/DK0869774T3/da
Priority to DE69625240T priority patent/DE69625240T2/de
Publication of SE9503672L publication Critical patent/SE9503672L/
Publication of SE505146C2 publication Critical patent/SE505146C2/sv
Priority to NO19981558A priority patent/NO320392B1/no
Priority to HK01108604.0A priority patent/HK1038309B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
SE9503672A 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning SE505146C2 (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE9503672A SE505146C2 (sv) 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning
DE69625240T DE69625240T2 (de) 1995-10-19 1996-09-03 Methode zur herstellung von partikeln mit verzoegerter freisetzung
PT96935641T PT869774E (pt) 1995-10-19 1996-09-03 Metodo para a producao de particulas de libertacao retardada
US09/051,709 US6120787A (en) 1995-10-19 1996-09-03 Sustained release particles
AU73478/96A AU699080B2 (en) 1995-10-19 1996-09-03 Sustained release particles
ES96935641T ES2125209T3 (es) 1995-10-19 1996-09-03 Metodo para fabricar particulas de liberacion sostenida.
EP01117830A EP1142569B1 (de) 1995-10-19 1996-09-03 Umhüllung kleiner Partikel
HK98112027.5A HK1011182B (en) 1995-10-19 1996-09-03 Method for manufacturing sustained release particles
JP9515728A JP2000501380A (ja) 1995-10-19 1996-09-03 持続放出性粒子
PCT/SE1996/001091 WO1997014408A1 (en) 1995-10-19 1996-09-03 Sustained release particles
AT01117830T ATE326953T1 (de) 1995-10-19 1996-09-03 Umhüllung kleiner partikel
KR1019980702757A KR100482262B1 (ko) 1995-10-19 1996-09-03 서방성입자
IL12405296A IL124052A (en) 1995-10-19 1996-09-03 Method of preparing parenterally administrable sustained release microparticles and microparticles obtainable thereby
CZ19981173A CZ293059B6 (cs) 1995-10-19 1996-09-03 Způsob přípravy mikročástic s trvalým uvolňováním
DE0869774T DE869774T1 (de) 1995-10-19 1996-09-03 Partikel mit verzögerter freisetzung
EP06010350A EP1716849A1 (de) 1995-10-19 1996-09-03 Umhüllung kleiner Partikel
DE69636177T DE69636177T2 (de) 1995-10-19 1996-09-03 Umhüllung kleiner Partikel
ES01117830T ES2267637T3 (es) 1995-10-19 1996-09-03 Revestimiento de pequeñas particulas.
CA 2234615 CA2234615C (en) 1995-10-19 1996-09-03 Sustained release particles
AT96935641T ATE228826T1 (de) 1995-10-19 1996-09-03 Methode zur herstellung von partikeln mit verzoegerter freisetzung
EP96935641A EP0869774B1 (de) 1995-10-19 1996-09-03 Methode zur herstellung von partikeln mit verzoegerter freisetzung
HU9901205A HUP9901205A3 (en) 1995-10-19 1996-09-03 Sustained release particles
DK96935641T DK0869774T3 (da) 1995-10-19 1996-09-03 Fremgangsmåde til fremstilling af vedvarende frigivende partikler
NO19981558A NO320392B1 (no) 1995-10-19 1998-04-06 Fremgangsmate for fremstilling av parenteralt administrerbare mikrokapsler med vedvarende frigivelse, og mikropartikler ifolge denne fremgangsmaten
HK01108604.0A HK1038309B (en) 1995-10-19 1998-11-16 Coating of small particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503672A SE505146C2 (sv) 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning

Publications (3)

Publication Number Publication Date
SE9503672D0 SE9503672D0 (sv) 1995-10-19
SE9503672L SE9503672L (sv) 1997-04-20
SE505146C2 true SE505146C2 (sv) 1997-06-30

Family

ID=20399887

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503672A SE505146C2 (sv) 1995-10-19 1995-10-19 Partiklar för fördröjd frisättning

Country Status (16)

Country Link
US (1) US6120787A (de)
EP (3) EP1716849A1 (de)
JP (1) JP2000501380A (de)
KR (1) KR100482262B1 (de)
AT (2) ATE228826T1 (de)
AU (1) AU699080B2 (de)
CZ (1) CZ293059B6 (de)
DE (3) DE69625240T2 (de)
DK (1) DK0869774T3 (de)
ES (2) ES2267637T3 (de)
HU (1) HUP9901205A3 (de)
IL (1) IL124052A (de)
NO (1) NO320392B1 (de)
PT (1) PT869774E (de)
SE (1) SE505146C2 (de)
WO (1) WO1997014408A1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045824A (en) * 1997-09-18 2000-04-04 Skyepharma Inc. Sustained-release liposomal anesthetic compositions
US20070212422A1 (en) * 1999-11-10 2007-09-13 Manfred Keller Dry powder for inhalation
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ES2169980B1 (es) * 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
IT1318380B1 (it) * 2000-03-09 2003-08-25 Intercos Italiana Polvere cosmetica rivestita.
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
ATE401095T1 (de) * 2000-05-26 2008-08-15 Frohwitter Bernhard Mittel zum erhalten und/oder korrigieren der blutglukosekonzentration
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
CA2424896A1 (en) 2000-10-06 2002-04-11 Jagotec Ag A controlled-release, parenterally administrable microparticle preparation
SE517421C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
SE517422C2 (sv) 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse
DE60138641D1 (de) 2000-10-27 2009-06-18 Baxter Healthcare Sa Herstellung von mikrokügelchen
SE518007C2 (sv) 2000-11-16 2002-08-13 Bioglan Ab Förfarande för framställning av mikropartiklar
US6967234B2 (en) * 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
US7030127B2 (en) * 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
US7034037B2 (en) * 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
US7105181B2 (en) 2001-10-05 2006-09-12 Jagotec, Ag Microparticles
AU2003216288B2 (en) 2002-02-13 2009-09-24 Duke University Modulation of immune response by non-peptide binding stress response polypeptides
SE0201599D0 (sv) 2002-03-21 2002-05-30 Skyepharma Ab Microparticles
US7326426B2 (en) * 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
US7368125B2 (en) * 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7026374B2 (en) * 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7101566B2 (en) * 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
CA2500661A1 (en) 2002-10-01 2004-04-15 Chiron Corporation Anti-cancer and anti-infectious disease compositions and methods for using same
US6872799B2 (en) 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
US6866860B2 (en) 2002-12-19 2005-03-15 Ethicon, Inc. Cationic alkyd polyesters for medical applications
US20040120981A1 (en) * 2002-12-20 2004-06-24 Aruna Nathan Crosslinked alkyd polyesters for medical applications
CA2510319A1 (en) * 2002-12-20 2004-07-15 Thomas J. Smith High pressure compaction for pharmaceutical formulations
US7060299B2 (en) * 2002-12-31 2006-06-13 Battelle Memorial Institute Biodegradable microparticles that stabilize and control the release of proteins
PT1638535E (pt) * 2003-06-26 2007-11-08 Mediolanum Pharmaceuticals Ltd Implantes subcutâneos com libertação inicial de princípio activo limitada e subsequente sua libertação extensiva com variação linear
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US8075919B2 (en) * 2003-07-18 2011-12-13 Baxter International Inc. Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
WO2005009375A2 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
KR100453273B1 (ko) * 2003-09-04 2004-10-15 주식회사 펩트론 초음파 이중공급노즐을 이용한 서방성 미립구의 제조 방법
US20060110423A1 (en) * 2004-04-15 2006-05-25 Wright Steven G Polymer-based sustained release device
US7456254B2 (en) * 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
CN1968700A (zh) * 2004-04-15 2007-05-23 阿尔克姆斯有限公司 聚合物基的持续释放装置
CN103393601A (zh) 2004-05-12 2013-11-20 巴克斯特国际公司 含有蛋白并在高浓度蛋白下显示可注射性的微球体
EP1765294B1 (de) 2004-05-12 2008-09-24 Baxter International Inc. Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US7884085B2 (en) * 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
EP1824460B1 (de) * 2004-11-10 2014-12-24 Tolmar Therapeutics, Inc. Stabilisiertes polymer-abgabesystem
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US8318210B2 (en) 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
US8017152B2 (en) * 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (de) 2005-05-27 2007-04-18 StratoSphere Pharma AB Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
US9693967B2 (en) 2005-09-07 2017-07-04 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
WO2007030545A2 (en) * 2005-09-07 2007-03-15 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates
US20070092553A1 (en) * 2005-10-21 2007-04-26 Pfab Lp Compositions and methods of making rapidly dissolving lonically masked formulations
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
GB0602897D0 (en) * 2006-02-13 2006-03-22 Jagotec Ag Improvements In Or Relating To Dry Powder Inhaler Devices
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
AU2007281737B2 (en) 2006-08-04 2013-09-19 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
GB0622818D0 (en) * 2006-11-15 2006-12-27 Jagotec Ag Improvements in or relating to organic compounds
GB0625303D0 (en) * 2006-12-19 2007-01-24 Jagotec Ag Improvements in and relating to metered dose inhalers
WO2008118712A1 (en) * 2007-03-22 2008-10-02 Alkermes, Inc. Coacervation process
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
CA2689101C (en) * 2007-05-30 2013-01-22 Neos Therapeutics, Lp Modifying drug release in suspensions of ionic resin systems
US20080317865A1 (en) * 2007-06-20 2008-12-25 Alkermes, Inc. Quench liquids and washing systems for production of microparticles
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
EP3323423B1 (de) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
KR101331136B1 (ko) 2011-01-12 2013-11-26 아주대학교산학협력단 약물의 초기 과다 방출 제어를 위한 약물전달 제형 및 이의 제조방법
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN110575445B (zh) 2013-03-21 2023-08-18 优普顺药物公司美国分部 可注射的持续释放组合物及其用于治疗关节炎症及相关疼痛的方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
AU2016343952A1 (en) 2015-10-27 2018-05-10 Eupraxia Pharmaceuticals Inc. Sustained release formulations of local anesthetics
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
KR102383448B1 (ko) * 2020-04-20 2022-04-06 한국화학연구원 락트산 또는 글리콜산을 포함하는 미립구형 서방출 제제 및 그의 제조방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117027A (en) * 1960-01-08 1964-01-07 Wisconsin Alumni Res Found Apparatus for coating particles in a fluidized bed
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
US4637905A (en) * 1982-03-04 1987-01-20 Batelle Development Corporation Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
AU7280387A (en) * 1986-04-07 1987-11-09 Rorer International (Overseas) Inc. Method for the preparation of a sustained release pharmaceutical composition and the compostion prepared thereby
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5275819A (en) * 1989-02-06 1994-01-04 Amer Particle Technologies Inc. Drug loaded pollen grains with an outer coating for pulsed delivery
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
CA2071867A1 (en) * 1989-11-06 1991-05-07 Edith Mathiowitz Method for producing protein microspheres
FR2663207B1 (fr) * 1990-06-15 1993-04-30 Rhone Poulenc Nutrition Animal Procede d'enrobage par un polymere ph sensible de principes actifs.
WO1992016191A1 (en) * 1991-03-25 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Long-acting pharmaceutical preparation
KR100259989B1 (ko) * 1991-10-01 2000-08-01 모리다 가쓰라 서방성 마이크로캡슐 제제 및 그의 제조법
US5288502A (en) * 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
JPH08503950A (ja) * 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres

Also Published As

Publication number Publication date
US6120787A (en) 2000-09-19
CZ117398A3 (cs) 1998-09-16
HUP9901205A3 (en) 2001-04-28
NO981558L (no) 1998-04-06
ES2125209T1 (es) 1999-03-01
KR19990064267A (ko) 1999-07-26
AU7347896A (en) 1997-05-07
DK0869774T3 (da) 2003-03-24
DE869774T1 (de) 1999-06-02
EP1142569A2 (de) 2001-10-10
DE69636177D1 (de) 2006-06-29
ES2125209T3 (es) 2003-07-01
SE9503672L (sv) 1997-04-20
SE9503672D0 (sv) 1995-10-19
NO981558D0 (no) 1998-04-06
CZ293059B6 (cs) 2004-01-14
KR100482262B1 (ko) 2006-04-14
PT869774E (pt) 2003-04-30
HUP9901205A2 (hu) 1999-08-30
ATE326953T1 (de) 2006-06-15
DE69636177T2 (de) 2007-03-29
HK1011182A1 (en) 1999-07-09
WO1997014408A1 (en) 1997-04-24
EP1142569B1 (de) 2006-05-24
EP1142569A3 (de) 2003-05-21
DE69625240T2 (de) 2003-09-11
JP2000501380A (ja) 2000-02-08
EP0869774A1 (de) 1998-10-14
DE69625240D1 (de) 2003-01-16
EP0869774B1 (de) 2002-12-04
NO320392B1 (no) 2005-11-28
ES2267637T3 (es) 2007-03-16
AU699080B2 (en) 1998-11-19
ATE228826T1 (de) 2002-12-15
EP1716849A1 (de) 2006-11-02
IL124052A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
AU699080B2 (en) Sustained release particles
EP1343478B1 (de) Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln
FI103183B (fi) Emulsioon perustuva menetelmä aineen mikrokapseloimiseksi mikrokapselo iduksi tuotteeksi
US6599627B2 (en) Microencapsulation of drugs by solvent exchange
SE512663C2 (sv) Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
EP2254560B1 (de) Zubereitung von nanoteilchen mit einer vibrierenden düsenvorrichtung
Bolzinger et al. Improvement of a bovine serum albumin microencapsulation process by screening design
SE518007C2 (sv) Förfarande för framställning av mikropartiklar
Singh et al. Sustained drug delivery using mucoadhesive microspheres: the basic concept, preparation methods and recent patents
CA2234615C (en) Sustained release particles
Harshitha et al. A Cutting-Edge Method for Regulated Drug Delivery-Microencapsulation
HK1011182B (en) Method for manufacturing sustained release particles
HK1038309B (en) Coating of small particles
HK1038309A1 (en) Coating of small particles
Akhtar et al. The New Developed Concepts and Trends in Microencapsulation

Legal Events

Date Code Title Description
NUG Patent has lapsed